(19)
(11) EP 4 815 989 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24898827.1

(22) Date of filing: 27.11.2024
(51) International Patent Classification (IPC): 
A61K 40/31(2025.01)
C07K 14/47(2006.01)
A61K 38/39(2006.01)
A61K 40/11(2025.01)
C07K 19/00(2006.01)
A61P 35/00(2006.01)
C07K 16/30(2006.01)
A61K 39/395(2006.01)
A61K 35/17(2025.01)
(52) Cooperative Patent Classification (CPC):
A61K 40/11; A61K 40/31; A61P 35/00; A61K 40/4255; A61K 40/33; A61K 40/4244; A61K 2239/54; A61K 40/4211; A61K 2239/59; A61K 31/519; A61K 31/16
 
C-Sets:
  1. A61K 31/519, A61K 2300/00;
  2. A61K 31/16, A61K 2300/00;

(86) International application number:
PCT/US2024/057896
(87) International publication number:
WO 2025/117851 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 30.11.2023 US 202363604730 P

(71) Applicant: The General Hospital Corporation
Boston, MA 02114 (US)

(72) Inventors:
  • MAUS, Marcela, V.
    Lexington, MA 02421 (US)
  • BERGER, Trisha, R.
    Worcester, MA 01606 (US)

(74) Representative: Maiwald GmbH 
Elisenhof Elisenstraße 3
80335 München
80335 München (DE)

   


(54) MESO-FAP WITH ADAM17 INHIBITOR OR ITK INHIBITOR